Leidos Holdings, Inc. (NYSE:LDOS) Shares Acquired by Daymark Wealth Partners LLC

Daymark Wealth Partners LLC boosted its position in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 10.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,618 shares of the aerospace company’s stock after purchasing an additional 839 shares during the period. Daymark Wealth Partners LLC’s holdings in Leidos were worth $1,242,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Millennium Management LLC boosted its stake in shares of Leidos by 156.5% during the 2nd quarter. Millennium Management LLC now owns 1,133,508 shares of the aerospace company’s stock valued at $165,356,000 after buying an additional 691,575 shares during the last quarter. FMR LLC raised its holdings in Leidos by 27.8% in the third quarter. FMR LLC now owns 2,405,726 shares of the aerospace company’s stock valued at $392,133,000 after acquiring an additional 522,764 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Leidos by 13.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,504,392 shares of the aerospace company’s stock valued at $571,216,000 after acquiring an additional 405,256 shares during the last quarter. International Assets Investment Management LLC grew its holdings in Leidos by 24,194.3% during the 3rd quarter. International Assets Investment Management LLC now owns 377,047 shares of the aerospace company’s stock worth $61,459,000 after acquiring an additional 375,495 shares in the last quarter. Finally, AQR Capital Management LLC increased its position in shares of Leidos by 76.9% in the 2nd quarter. AQR Capital Management LLC now owns 698,807 shares of the aerospace company’s stock worth $101,942,000 after purchasing an additional 303,775 shares during the last quarter. 76.12% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

LDOS has been the topic of several research analyst reports. JPMorgan Chase & Co. increased their price target on shares of Leidos from $175.00 to $185.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Robert W. Baird increased their target price on Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Royal Bank of Canada boosted their price target on Leidos from $145.00 to $180.00 and gave the company a “sector perform” rating in a report on Wednesday, October 30th. Truist Financial reduced their price objective on Leidos from $205.00 to $185.00 and set a “buy” rating on the stock in a research note on Friday, November 22nd. Finally, Citigroup boosted their target price on shares of Leidos from $194.00 to $220.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. Five research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $179.07.

Insider Buying and Selling

In other news, Director Surya N. Mohapatra sold 2,748 shares of the business’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $194.97, for a total transaction of $535,777.56. Following the transaction, the director now directly owns 20,001 shares in the company, valued at $3,899,594.97. The trade was a 12.08 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the company’s stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $184.94, for a total transaction of $193,632.18. Following the completion of the transaction, the director now directly owns 6,408 shares in the company, valued at $1,185,095.52. This trade represents a 14.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.96% of the company’s stock.

Leidos Stock Performance

LDOS opened at $161.27 on Thursday. The business has a 50 day moving average price of $155.29 and a two-hundred day moving average price of $158.27. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.23 and a quick ratio of 1.15. The company has a market capitalization of $21.52 billion, a price-to-earnings ratio of 18.37, a price-to-earnings-growth ratio of 1.05 and a beta of 0.66. Leidos Holdings, Inc. has a 1-year low of $108.95 and a 1-year high of $202.90.

Leidos (NYSE:LDOS) last announced its quarterly earnings data on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share for the quarter, beating the consensus estimate of $1.96 by $0.97. The business had revenue of $4.19 billion during the quarter, compared to analyst estimates of $4.06 billion. Leidos had a return on equity of 30.31% and a net margin of 7.37%. The company’s revenue was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.03 earnings per share. Research analysts predict that Leidos Holdings, Inc. will post 10.03 EPS for the current fiscal year.

Leidos Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 16th were paid a dividend of $0.40 per share. The ex-dividend date was Monday, December 16th. This is a positive change from Leidos’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 0.99%. Leidos’s dividend payout ratio is currently 18.22%.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.